{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:34:55Z","timestamp":1790238895459,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:00:00Z","timestamp":1357776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053016","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T17:13:35Z","timestamp":1357838015000},"page":"e53016","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Andreas D.","family":"Kistler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Siwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Poster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Krauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mrug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared J.","family":"Grantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongtae T.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Bost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene B.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"issue":"Suppl 328","key":"ref1","first-page":"1","article-title":"Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families","author":"OZ Dalgaard","year":"1957","journal-title":"Acta Med Scand"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980","volume":"2","author":"CG Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group","volume":"353","author":"N Hateboer","year":"1999","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ackd.2009.12.004","article-title":"Determinants of renal disease variability in ADPKD","volume":"17","author":"PC Harris","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease","volume":"5","author":"AB Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"PA Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease","volume":"8","author":"AM Johnson","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"VE Torres","year":"2007","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000254338","article-title":"Autosomal dominant polycystic kidney disease: new treatment options and how to test their efficacy","volume":"32","author":"RP Wuthrich","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified Criteria for Ultrasonographic Diagnosis of ADPKD","volume":"20","author":"Y Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","article-title":"Molecular diagnostics for autosomal dominant polycystic kidney disease","volume":"6","author":"PC Harris","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1681\/ASN.2006090956","article-title":"Advances in urinary proteome analysis and biomarker discovery","volume":"18","author":"D Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1470-2045(06)70584-8","article-title":"Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis","volume":"7","author":"D Theodorescu","year":"2006","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/prca.201000155","article-title":"Human urinary peptide database for multiple disease biomarker discovery","volume":"5","author":"J Siwy","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e13421","DOI":"10.1371\/journal.pone.0013421","article-title":"Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy","volume":"5","author":"A Alkhalaf","year":"2010","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2008.0040","article-title":"Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease","volume":"11","author":"JK Snell-Bergeon","year":"2009","journal-title":"Diabetes Technol Ther"},{"key":"ref17","article-title":"Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy","author":"P Zurbig","year":"2012","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.2009.93","article-title":"Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease","volume":"76","author":"AD Kistler","year":"2009","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes","volume":"1","author":"JJ Grantham","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"AL Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"F1423","DOI":"10.1152\/ajprenal.00275.2007","article-title":"Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1","volume":"293","author":"T Weimbs","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000103912","article-title":"Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease","volume":"27","author":"D Bolignano","year":"2007","journal-title":"Am J Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbrc.2007.10.103","article-title":"Kidney injury molecule 1 (Kim1) is a novel ciliary molecule and interactor of polycystin 2","volume":"364","author":"EW Kuehn","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2010.06.023","article-title":"Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis","volume":"56","author":"E Meijer","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref25","article-title":"Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury","author":"J Metzger","year":"2010","journal-title":"Kidney Int"},{"key":"ref26","article-title":"Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease","author":"AB Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1021\/ac050983o","article-title":"Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease","volume":"77","author":"MJ Chalmers","year":"2005","journal-title":"Anal Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mas.20205","article-title":"Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments","volume":"28","author":"H Mischak","year":"2009","journal-title":"Mass Spectrom Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1242\/dmm.003194","article-title":"The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation","volume":"3","author":"S Mangos","year":"2010","journal-title":"Dis Model Mech"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.ki.5002627","article-title":"Overexpression of innate immune response genes in a model of recessive polycystic kidney disease","volume":"73","author":"M Mrug","year":"2008","journal-title":"Kidney Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/ndt\/gfl071","article-title":"Gene profiling of polycystic kidneys","volume":"21","author":"G Schieren","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00022744-199812000-00008","article-title":"Histogenesis of the cysts in the autosomal dominant polycystic kidney disease - An immunohistochemical study","volume":"6","author":"A Therezo","year":"1998","journal-title":"Applied Immunohistochemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","article-title":"Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats","volume":"60","author":"BD Cowley Jr","year":"2001","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","article-title":"Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease","volume":"14","author":"D Zheng","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2215\/CJN.04560510","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease","volume":"6","author":"E Meijer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref36","article-title":"Evaluation of urine biomarkers of kidney injury in polycystic kidney disease","author":"CR Parikh","year":"2012","journal-title":"Kidney Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ki.2011.30","article-title":"Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine","volume":"79","author":"W Gronwald","year":"2011","journal-title":"Kidney Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2369-8-13","article-title":"Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study","volume":"8","author":"AL Serra","year":"2007","journal-title":"BMC Nephrology"},{"key":"ref39","first-page":"NEJMoa0907419","article-title":"Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease","author":"AL Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2008.558","article-title":"Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months","volume":"75","author":"AD Kistler","year":"2009","journal-title":"Kidney Int"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"64","author":"AB Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume Progression in Polycystic Kidney Disease","volume":"354","author":"JJ Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/HJH.0b013e32833d81b7","article-title":"Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals","volume":"28","author":"C Delles","year":"2010","journal-title":"J Hypertens"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1074\/mcp.M800529-MCP200","article-title":"Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"8","author":"M Haubitz","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-09-0226","article-title":"Prediction of muscle-invasive bladder cancer using urinary proteomics","volume":"15","author":"E Schiffer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"DM Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/ndt\/gfp063","article-title":"Urinary proteome pattern in children with renal Fanconi syndrome","volume":"24","author":"J Drube","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref48","article-title":"Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease","author":"AD Kistler","year":"2009","journal-title":"Kidney Int"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rcm.1294","article-title":"Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption\/ionization and capillary electrophoresis\/mass spectrometry","volume":"18","author":"N Neuhoff","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/elps.200400208","article-title":"Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine","volume":"26","author":"D Theodorescu","year":"2005","journal-title":"Electrophoresis"},{"key":"ref51","article-title":"CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics","author":"J Coon","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bioinformatics\/btf877","article-title":"Identifying differentially expressed genes using false discovery rate controlling procedures","volume":"19","author":"A Reiner","year":"2003","journal-title":"Bioinformatics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm1384","article-title":"Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis","volume":"12","author":"S Decramer","year":"2006","journal-title":"Nat Med"},{"key":"ref54","article-title":"Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience","author":"H Mischak","year":"2012","journal-title":"Clin Biochem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/elps.200500827","article-title":"Biomarker discovery by CE-MS enables sequence analysis via MS\/MS with platform-independent separation","volume":"27","author":"P Zurbig","year":"2006","journal-title":"Electrophoresis"}],"updated-by":[{"DOI":"10.1371\/annotation\/9281c713-d253-4a1a-8255-92e691e77a24","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:00:00Z","timestamp":1375747200000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T13:49:49Z","timestamp":1644068989000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053016"}},"subtitle":[],"editor":[{"given":"John Matthew","family":"Koomen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717979266.793471196","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,10]]}}}